The aim of this study was to evaluate the potential of culture-expanded human auricular and nasoseptal chondrocytes as cell source for regeneration of stable cartilage and to analyze the differences in gene expression profile of expanded chondrocytes from these specific locations. Auricular chondrocytes in monolayer proliferated less and more slowly (two passages took 26.7 ± 2.1 days and were reached in 4.37 ± 0.30 population doublings) than nasoseptal chondrocytes (19.3 ± 2.5 days; 5.45 ± 0.20 population doublings). However, auricular chondrocytes produced larger pellets with more cartilage-like matrix than nasoseptal chondrocytes (2.2 ± 0.71 vs. 1.7 ± 0.13 mm in diameter after 35 days of culture). Although the matrix formed by auricular and nasoseptal chondrocytes contained collagen X, it did not mineralize in an in vitro model or after in vivo subcutaneous implantation. A DNA microarray study on expanded auricular and nasoseptal chondrocytes from the same donors revealed 1,090 differentially expressed genes. No difference was observed in the expression of known markers of chondrogenic capacity (e.g., collagen II, FGFR3, BMP2, and ALK1). The most striking differences were that the auricular chondrocytes had a higher expression of anabolic growth factors BMP5 and IGF1, while matrix-degrading enzymes MMP13 and ADAMTS5 were higher expressed in nasoseptal chondrocytes. This might offer a possible explanation for the observed higher matrix production by auricular chondrocytes. Moreover, chondrocytes isolated from auricular or nasoseptal cartilage had specific gene expression profiles even after expansion. These differently expressed genes were not restricted to known characterization of donor site subtype (e.g., elastic), but were also related to developmental processes.
INTRODUCTION
research has been performed on cartilage regenerative medicine in this specialty (34, 43) . However, recent developments such as the first patient receiving a tissueDevelopments in regenerative medicine offer promise for the reconstruction of damaged tissues and organs, engineered trachea (23) and the clinical application of cultured autologous auricular chondrocytes to treat craincluding cartilage (40) . In orthopedics, cartilage regenerative medicine has been used clinically to treat focal niofacial or nasal augmentation (46) and microtia (45) underline the future possibilities of cartilage regenerajoint defects with autologous chondrocyte implantation (ACI) since the first study in patients in 1994 (2). For tive medicine. Naturally, in otorhinolaryngology and head and neck surgery chondrocyte sources other than this procedure, expanded articular chondrocytes are used. In otorhinolaryngology and head and neck surgery, articular cartilage might be a better choice.
To select a cartilage donor source for cell therapy, cartilage regenerative medicine may offer a promising alternative to the current use of auricular or costal cartione should consider at least three important things: the amount of cartilage that can be harvested without doing lage to reconstruct cartilage defects. Unfortunately, less harm to the function of the cartilage structure at the domight lead to more insight into the capacity of the cell sources. Furthermore, these types of characterizations nor site, the invasiveness of the biopsy procedure, and the difference in chondrogenic phenotype (e.g., hyaline before use can be expected to become more important in regenerative medicine. If culture-expanded auricular vs. elastic) of the original tissue. From the first two standpoints nasoseptal and especially auricular cartilage or nasoseptal chondrocytes are to be used in the future clinically, they should also be better characterized. should be considered as favorable chondrocyte sources. Although articular chondrocytes have been extensively
In this study, we demonstrate the potential of human auricular and nasoseptal chondrocytes as cell source for characterized and studied for their chondrogenic regeneration potential, overall fewer studies using alternative cartilage regenerative medicine. We investigate the general performance of these cells, focusing on subtype and cell sources have been published (1, 14, 18, 41) .
Auricular cartilage is elastic from origin and exstability of tissue-engineered constructs. Finally, we performed a DNA microarray study on expanded auricular panded auricular chondrocytes may therefore produce a different cartilage matrix than expanded articular chonand nasoseptal chondrocytes from the same donors in a first attempt to characterize these cells in more detail to drocytes. Although harvesting nasoseptal cartilage would not be as minimally invasive as auricular cartilage, it evaluate differences as well as potential similarities in phenotype after expansion. does have the potential benefit to originate from hyaline cartilage. However, both donor cell sources differ from MATERIALS AND METHODS articular cartilage in one other major aspect: the presCell Sources ence of a perichondrium.
An important requirement for tissue-engineered cartiFrom four donors (age 18, 26, 28, 47) undergoing lage is that it is stable and will not mineralize upon imrhinoplasty using ear cartilage, both ear and nasoseptal plantation for reconstruction. Therefore, recent studies cartilage were obtained (MEC-2005-359) . Additionally, comparing different cell sources or culture systems did auricular cartilage was obtained from in total four donot only evaluate chondrogenic capacity, but took the nors (age 5, 7, 9, 13) undergoing protruding ear reconstability of the tissue-engineered cartilage in considerstruction (MEC-2006-186) . Nasoseptal cartilage was obation; while articular chondrocytes produced stable hyatained as leftover material from two donors (age 33, 65) line cartilage that did not mineralize (25, 33) , bone marundergoing rhinoplasty (MEC-2005-359 ). row-derived mesenchymal stem cells (BMSCs) displayed
The first aim of this study was to evaluate the potensigns of chondrocyte hypertrophy (i.e., production of tial of culture-expanded human auricular and nasoseptal collagen X) (11, 13, 17, 27, 33) and mineralized in vivo chondrocytes as cell source for regeneration of stable (5,33). In these comparisons auricular and nasoseptal cartilage. Because it is known from previous studies that chondrocytes were not taken into account. articular chondrocytes form stable hyaline cartilage, Results from studies on expanded articular chondrowithout collagen X expression and mineralization (25, cytes cannot be translated to expanded auricular or naso-33), we used these cells as negative controls for hyperseptal chondrocytes as auricular cartilage is elastic and trophic differentiation. Healthy, articular cartilage was auricular and nasoseptal cartilage differ from the former obtained as leftover material from two donors (age 3, 8) by their perichondrium. While the outer fibrous periundergoing triple arthrodesis to treat clubfoot deformity chondrium can be easily removed from cartilage, this is (MEC-2007-032). Because BMSCs are known to bevery difficult for the inner layer (i.e., cambium) of the come hypertrophically differentiated and mineralize in perichondrium. Undifferentiated progenitor cells in this vivo (5,11,13,17,27,33) these cells were used as a posicambium layer are responsible for new cartilage formative control. BMSCs were isolated from a femoral shaft tion (9,36,39,42), but it is possible that culturing progenbiopsy of four donors (age 30, 42, 51, 60) undergoing itor cells from the cambium layer gives rise to rather total hip replacement, after informed consent had been unstable cartilage-like constructs, similar to those arising obtained in accordance with the local ethical committee from BMSCs. Therefore, it is essential to evaluate the (MEC-2004-142 ). mineralization potential of auricular and nasoseptal Cell Isolation and Expansion chondrocytes when considering them for reconstructions. To our knowledge this has never been done.
For isolation of chondrocytes, cartilage slices were rinsed with saline after careful resection of the (fibrous) As expanded articular chondrocytes at the moment are clinically used for ACI, recent studies focus on betperichondrium, and subsequently digested through incubation for 2 h at 37°C with 2 mg/ml pronase E (Sigmater characterization of the molecular phenotype of the cells (8, 35) . In fact, some markers are defined that are Aldrich, St. Louis, MO, USA), followed by overnight incubation with 1.5 mg/ml collagenase B (Boehringer predictive of the capacity of these expanded chondrocytes to form stable cartilage (8,12). Characterization Mannheim, Germany) in DMEM containing glutamax (Gibco, Carlsbad, CA, USA) and 10% fetal calf serum precoated with collagen II (Sigma-Aldrich), and centrifuged in a 24-well plate for 5 min at 200 × g (28). Chon-(FCS) (Gibco). Next, cell suspensions were filtered through a 100-µm filter, centrifuged, and washed with drocytes were cultured on "chondrogenic differentiation medium" with medium refreshment three times a week. saline. For expansion, chondrocytes were seeded at a density of 7,500 cells/cm 2 in "chondrocyte-expansion General Performance of Auricular Versus medium" [DMEM containing glutamax, with 10% FCS Nasoseptal Chondrocytes and 1.5 µg/ml fungizone (Gibco) and 50 µg/ml gentamicin (Gibco)]. At subconfluency cells were trypsinized
To directly compare the performance of auricular and nasoseptal chondrocytes, ear and nasoseptal cartilage and further expanded. Chondrocytes from passage (P) 2 were used for the experiments. Small pieces of auricular from the same donor were used, for a total of three donors (age 26, 28, 47). The performance was evaluated and nasoseptal cartilage were kept aside for immunohistochemical characterization.
in monolayer expansion by number of population doublings until subconfluency and time to subconfluency. For isolation of BMSCs the heparinized bone marrow aspirate was seeded at a density of 2-5 × 10 5 cells/cm 2 All chondrocytes were expanded and trypsinized when subconfluency was reached. Chondrocytes from passage in "BMSC expansion medium" [DMEM-LG (Gibco), supplemented with 10% FCS, 1 ng/ml FGF2 (AbD Ser-2 were chondrogenically differentiated for 35 days in pellet culture. To measure the size of the chondrogenic otec, Kidlington, UK), 25 µg/ml ascorbic acid-2-phosphate (Sigma-Aldrich), 1.5 µg/ml fungizone, and 50 µg/ pellet at day 35, a picture was taken of the intact pellet together with a stage micrometer at 10× magnification. Characterization of subtype differentiation was studBMSCs as controls, were chondrogenically differentiied on pellet cultures at day 35 from auricular and nasoated in pellet cultures. Cells were cultured in pellets by septal chondrocytes from all donors. This was compared centrifuging aliquots of 2 × 10 5 cells in 0.5 ml medium with pellet cultures from articular chondrocytes and at 200 × g for 8 min in a polypropylene tube. ChondroBMSCs, which are known to produce hyaline and hypergenic differentiation was induced by "chondrogenic diftrophic cartilage, respectively, as well as with sections ferentiation medium" based on previous publications of native auricular and nasoseptal cartilage. In the flat (3,13,19), consisting of DMEM containing glutamax, constructs the cartilage subtype differentiation was eval-ITS+1 (B&D Bioscience, Bedford, MA, USA), 40 µg/ uated before and after in vivo implantation. Characterml L-proline (Sigma-Aldrich), 1 mM sodium-pyruvate ization of cartilage subtype differentiation was per-(Gibco), 5 µg/ml fungizone, 50 µg/ml gentamicin, 25 formed through immunohistochemistry of collagen II, µg/ml ascorbic acid-2-phosphate, 10 ng/ml TGF-β2 collagen X, and elastin. (R&D Systems, Minneapolis, MN, USA), and 10 −7 M To study the effect of passage number on subtype dexamethasone (Sigma-Aldrich). The medium was differentiation, chondrocytes from two auricular, nasochanged two times a week.
septal, and articular donors were not only differentiated at passage 2 but also at passage 4 and 6. Flat Constructs. To study in vivo stability of tissueengineered cartilage from auricular and nasoseptal chonStability of Tissue-Engineered Cartilage drocytes larger and flat constructs were used because these resemble the clinical need better than pellets. AuTo study the ability to mineralize the matrix as a measure of stability, 10 mM β-glycerophosphate (BGP) ricular and nasoseptal chondrocytes from one donor (age 18) were used for this experiment. Aliquots of 5 × 10 5 was added to the medium of pellets after cartilage formation had started. Based on previous studies, BGP was auricular chondrocytes or nasoseptal chondrocytes (suspended in 100 µl "chondrogenic differentiation meadded to the medium of auricular and nasoseptal chondrocytes from day 14 on, and these pellets were hardium") were pipetted onto a dry 6.5-mm diameter, 0. To study whether the flat constructs harvested after medium of these pellets from day 35 on, and pellets were harvested at day 49.
in vivo implantation were from human origin, a monoclonal mouse anti-human vimentin antibody (AMF-17b, To confirm the stable phenotype of auricular-and nasoseptal-derived tissue-engineered constructs that was Developmental Studies Hybridoma Bank, 1:40) was used. To exclude any unspecific binding of the vimentin seen in the previous in vitro model, a subsequent experiment was performed implanting tissue-engineered conantibody to mouse IgGs, the mouse-on-mouse HRPPolymer Kit (Biocare Medical, Concord, CA, USA) was structs in vivo. To directly compare the auricular and nasoseptal chondrocytes, cartilage from one single donor used, according to the manufacturer's instructions with some small modifications. In short, slides were incu-(age 18) was used for this experiment and cells were trypsinized simultaneously. Cells were cultured on a bated in an aqueous 3% solution of hydrogen peroxidase, to inhibit any endogenous peroxidase and allow Transwell filter as flat constructs because these resemble the clinical need better than pellets. As in the previous for a peroxidase-antiperoxidase staining method. Antigen retrieval for vimentin was performed through incuexperiment cells were chondrogenically differentiated for 14 days. At this time, six flat constructs were harbation in Rodent Decloaker for 60 min at 95°C. Nonspecific binding sites were blocked with Rodent Block vested for histology and biochemistry and eight flat constructs were implanted into the back of a nude mouse.
M and sections were stained overnight with vimentin (V6630, Sigma-Aldrich, 1:40). The MM-polymer-HRP Four 6-week-old male NMRI nu/nu mice (Taconic, Germantown, NY, USA) were used. Two incisions were secondary antibody was used, followed by incubation with 3′-diaminobenzidine chromogen solution (Sigmamade along the central line of the spine of the mouse, one at the shoulders and one at the hips. Two auricularAldrich) to demonstrate positivity for the antibody with a brown staining. A mouse monoclonal negative control chondrocyte constructs and two nasoseptal-chondrocyte constructs were implanted per mouse. Animals were terantibody (Dako) was used as an isotype control. Slides were counterstained with hematoxylin. minated 6 weeks later to harvest the cartilage constructs for histology. This procedure was carried out with apVon Kossa/Thionin Staining. For evaluation of minproval from the animal ethical committee (EUR1428).
eralization, slides were immersed in 5% silver nitrate solution (Sigma, St. Louis, MO, USA) for 10 min, (Immuno)histochemistry rinsed in ultrapure water, and exposed to light for 10 Constructs were fixed in 4% formalin in phosphatemin. Excess silver nitrate was removed with 5% sodiumbuffered saline (PBS), set in 2% agar, and embedded in thiosulphate (Sigma) and cells were rinsed in distilled paraffin.
water. Sections were counterstained with 0.4% thionin Immunohistochemistry for Collagen II, Collagen X, in 0.01 M aqueous sodium acetate, pH 4.5, for 5 min, Elastin, and Vimentine. Antigen retrieval for collagen II which aside from staining the nucleus also demonstrates was performed through incubation with 0.1% pronase glycosaminoglycan (GAG) content. (Sigma-Aldrich) in PBS for 30 min, while antigen reBiochemistry trieval for collagen X required 0.1% pepsin (SigmaAldrich) in 0.5 M acetic acid (pH 2.0) for 2 h. Both Flat constructs were digested overnight at 56°C in 1 mg/ml proteinase K (Sigma-Aldrich) in Tris/EDTA collagen II and collagen X stainings continued with incubation with 1% hyaluronidase (Sigma-Aldrich) in buffer (pH 7.6) containing 185 µg/ml iodoacetamide and 1 µg/ml pepstatin A (Sigma-Aldrich). GAG amount was PBS for 30 min. Antigen retrieval for elastin was performed through incubation with 0.25% trypsin (Sigma) quantified using dimethylmethylene blue (DMB) assay (10). The metachromatic reaction of GAG with DMB in PBS for 20 min.
Nonspecific binding sites were blocked with 10% was monitored with a spectrophotometer, and the ratio A530:A590 was used to determine the GAG amount, goat serum in PBS and sections were stained overnight with primary antibodies against collagen II (II/II6B3, using chondroitin sulfate C (Sigma) as a standard. To determine the amount of DNA, each proteinase K-digested Developmental Studies Hybridoma Bank, 1:100), collagen X (Quartett, Berlin, Germany, 1:10), and elastin sample (50 µl) was treated with 100 µl heparin (8.3 IU/ ml in PBS) and 50 µl ribonuclease A (50 µg/ml in PBS) (BA4, Sigma-Aldrich, 1:1000). To allow the use of monoclonal mouse antibodies on tissue-engineered cartifor 30 min at 37°C. This was followed by adding 50 µl ethidium bromide solution (25 µg/ml in PBS). Samples lage constructs implanted in a nude mouse, we used a were analyzed on the Wallac 1420 victor2 (Perkin-Elmer, sion 1.1 where control probes were extracted and normalized using the default RMA algorithm. The area Wellesley, MA, USA) using an extinction filter of 340 nm and an emission filter of 590 nm. For standards, calf under the curve (AUC) of the Receiver Operator Characteristic was calculated using positive and negative conthymus DNA (Sigma-Aldrich) was used.
Statistical analysis was conducted with Microsoft Oftrol probes. All arrays had an AUC score above the empirically defined threshold of 0.85, indicating a good fice Excel 2007. Values are represented as mean ± SD. An unpaired t-test was performed to compare GAG separation of positive and negative controls. Pearson correlation coefficients were determined for each and amount. The level of significance was set at a value of p < 0.05. every combination of arrays. For each of the two tissues a cluster of high correlation was revealed. One of the Microarray Study three auricular samples of one donor did not show higher correlation to the arrays in the cluster of its tissue Both auricular and nasoseptal cartilage were harvested from the same donor, two donors in total (age 28, and was therefore considered an outlier and excluded from further analysis (Fig. 1) . Next, the CEL-files were 47). Cells were trypsinized at 80% confluency, as judged by the same observer. To avoid a bias in gene imported into Partek Genomic Suite software (version 6.4, Partek Inc., St. Louis, MO, USA) where only core expression data by differences in culture procedures, all cells from P2, P4, and P6 were plated in 24-well plate probe sets were extracted and normalized using the RMA algorithm with GC background correction. Core at high cell density (50,000 NC/cm 2 ) in "chondrocyteexpansion medium." After 3 days the medium was retranscript summaries were calculated using the mean intensities of the corresponding probe sets, representing placed, followed by harvesting of the cells exactly 24 h later. Therefore, from each donor three samples per cell the quantitative expression levels of 17,881 genes. The correspondence of the replicate samples was source were available, offering the possibility to statistically adjust for between-donor differences. Cells from confirmed using principle component analysis (PCA) and Pearson correlation analysis. p-Values and fold dif-P2, P4, and P6 were also chondrogenically differentiated in pellets to determine the chondrogenic capacity after ferences for the expression differences between auricular and nasoseptal chondrocytes were generated by expansion.
applying an ANOVA model. p-Values were corrected RNA Isolation and Expression Profiling for multiple testing using the Benjamini-Hochberg method. Genes with values of p < 0.05 and fold differFor total RNA isolation, cells were manually homogenized in RNA-BeeTM (TEL-TEST, Friendswood, TX, ences higher than 2 were functionally annotated and classified by using the functional annotation clustering USA). RNA was extracted with chloroform and purified from the supernatant using the RNAeasy Micro Kit (Qitool of Database for Annotation, Visualization, and Integrated Discovery (DAVID) (http://david.abcc.ncifcrf.gov/) agen, Hilden, Germany), according to the manufacturer's guidelines with on-column DNA digestion. Gene (16) . expression profiling was performed using Affymetrix
Quantitative Real-Ttime RT-PCR 1.0 Human Exon ST arrays, representing all known genes (Affymetrix Inc., Santa Clara, CA, USA) accordTo validate the results from the microarray analysis, the three genes with the highest fold difference between ing to the manufacturer's instructions. The Affymetrix GeneChip Whole Transcript Sense Target Labeling auricular and nasoseptal chondrocytes and the three genes with a fold difference closest to 2 were analyzed Assay (kit 900652; 1.0 µg of total RNA) was used to generate amplified and biotinylated sense strands DNA by RT-PCR.
Complementary DNA (cDNA) was made using Retargets from the entire expressed genome. The manufacturer's instruction (version 4, P/N 701880 Rev. 4) was vertAid TM First Strand cDNA Synthesis Kit (MBI Fermentas, Germany) and polymerase chain reactions were followed for the hybridization, washing, and scanning steps. Arrays were hybridized by rotating them at 60 performed using TaqMan Universal PCR MasterMix (Applied Biosystems, Capelle a/d Ijssel, Netherlands) on rpm in the Affymetrix GeneChip hybridization oven at 45°C for 17 h. After hybridization, the arrays were an ABI PRISM 7000 (Applied Biosystems, Foster City, CA, USA). Taqman gene-expression assays were washed in the Affymetrix GeneChip Fluidics station FS 450. Arrays were scanned using the Affymetrix Genepurchased from Applied Biosystems for STEAP4 (Hs00226415_m1), ALX1 (Hs00232518_m1), IL31RA Chip scanner 3000 7G system.
(Hs00371172_m1), GRK5 (Hs00992173_m1), and TMED3 Data Extraction and Statistical Analyses (Hs00201251_m1). Primer sequences for GAPDH and PRG4 are described elsewhere (6). For quality control, the Affymetrix CEL-files were first imported into Affymetrix Expression Console verExpression was normalized to GAPDH and expressed relatively using the 2-∆Ct formula (22) . Subsequently, lar-chondrocyte pellet was 2.2 ± 0.71 mm, the average diameter of a pellet of nasoseptal chondrocytes was 1.7 ± fold differences for each gene were calculated between auricular and nasoseptal chondrocytes. 0.13 mm.
RESULTS

Cartilage Subtype Differentiation General Performance
All pellets of expanded auricular and nasoseptal chondrocytes produced cartilage, as was evaluated with To directly compare the performance of auricular and nasoseptal chondrocytes, ear and nasoseptal cartilage thionin staining showing proteoglycans and immunohistochemistry for collagen type II ( Fig. 2A, D) . Pellets from the same donor were used for this experiment, for a total of three donors (age 26, 28, 47). After isolation, of both auricular and nasoseptal chondrocytes expressed collagen X (Fig. 2B, E) , independent of donor age or the auricular chondrocytes adhering to the flask varied tremendously in morphology and size while nasoseptal passage number, indicating hypertrophic differentiation. In comparison, articular chondrocytes produced abunchondrcytes were all round and of similar size. Upon culturing the auricular chondrocytes became more and dant collagen type II but no collagen type X (Fig. 2G,  H) , as was also demonstrated in previous studies. more uniform in their appearance.
Auricular chondrocytes had gone through 4.37 ± 0.30 BMSCs, known for their potential to generate terminally differentiated chondrogenic pellets and the ability to population doublings in two passages, while nasoseptal chondrocytes had gone through 5.45 ± 0.20 population mineralize, did indeed express both collagen II and collagen X in our experiment (Fig. 2I, J) . Pellets of chondoublings (p = 0.026). It took 26.7 ± ± 2.1 days for auricular chondrocytes and 19.3 ± 2.5 days for nasoseptal drocytes of all sources produced less cartilage-like matrix with increasing passage number (data not shown). chondrocytes to perform 2 passages (p = 0.014).
Chondrocytes isolated from auricular cartilage proNo elastin was detected in pellets from any of the cell sources, including auricular chondrocytes. Even duced significantly larger (p = 0.023) cartilage-like constructs ( Fig. 2A-F) . The average diameter of an auricuafter prolonged culturing (70 days) or when primary au-ricular chondrocytes were used, no elastin was observed tive cartilage the chondrocytes were isolated from, as in vitro nasoseptal chondrocytes produced collagen X and in the matrix. This suggests that either the in vitro model does not support elastin production of these cells, or that auricular chondrocytes did not produce any elastin. mature elastic chondrocytes are incapable of elastin synStability of Tissue-Engineered Cartilage thesis.
In comparison, native nasoseptal cartilage stained Because auricular and nasoseptal chondrocytes formed cartilage positive for collagen X, a marker for hypertropositively for collagen II, but not for collagen X or elastin. Native auricular cartilage (independent of age), on phic cartilage, we studied the ability to mineralize as a measure of stability of the tissue-engineered cartilage the other hand, stained positively for elastin and collagen type II, as well as collagen X. Therefore, the tissueformed by auricular and nasoseptal chondrocytes. In this in vitro model chondrocytes from one common donor engineered cartilage differed molecularly from the na- Von Kossa/thionin staining demonstrates a proteoglycan-rich matrix at day 35 without mineralization when BGP was added to the medium for the last 3 weeks (C, F). At day 35 articular chondrocytes had produced collagen II (G), but not collagen X (H) and BMSCs had produced collagen II (I) as well as collagen X (J). Von Kossa/thionin staining demonstrates abundant mineralization in BMSC pellets when BGP was added to the medium from day 35 to 49 (K). Pellets of auricular and nasoseptal chondrocytes are from the same donor. Note that pellets of auricular chondrocytes (A-C) were larger and contained more cartilage-like matrix than nasoseptal chondrocytes (D-F).
(age 26) as well as with two distinct donors (auricular cartilage constructs, except one from nasoseptal chondrocytes, were recognizable and could be harvested. donors aged 9 and 13, nasoseptal donors aged 33 and 65) were used. In auricular and nasoseptal chondrocyte Constructs from auricular chondrocytes were larger and therefore better recognizable in vivo than those from napellets a collagen II-rich matrix had formed at day 14 and collagen X was present at this time in the pellets of soseptal chondrocytes. Moreover, these constructs were stiff and strong on handling, while constructs from nasoall except one nasoseptal chondrocyte donor. At the end of the culture period both collagen II and collagen X septal chondrocytes were still fragile and also macroscopically did not resemble cartilage. Immunohistowere observed in all pellets. Addition of β-glycerophosphate was used to evaluate the capacity to mineralize, chemistry demonstrated a rich collagen II and collagen X containing matrix in all harvested constructs of both resulting in a positive Von Kossa staining in BMSC pellets (donor age 30, 42), which served as a positive mincell sources (Fig. 3A-D) . Elastin was demonstrated in the matrix of auricular-chondrocyte constructs, but not eralization control (Fig. 2K) . No mineralization was observed in any of the pellets of either auricular or in nasoseptal chondrocytes (Fig. 3E, F) . Von Kossa/thionin staining demonstrated a proteoglycan-rich matrix in nasoseptal chondrocytes (Fig. 2C, F) .
To compare the performance of auricular and nasoconstructs from both cell sources, while no mineralization was present after 6 weeks of subcutaneous implanseptal chondrocytes in vivo in an application set-up, auricular and nasoseptal cells were harvested from the one tation (Fig. 3G, H) . By means of a vimentin staining, the cartilage-like constructs were demonstrated to be of donor (age 18) seeded in monolayer for expansion and trypsinized simultaneously. Nasoseptal chondrocytes human origin, while surrounding fibrous tissue was of murine origin (Fig. 3I, J) . had gone through 5.4 population doublings and auricular chondrocytes through 2.0 population doublings. Therefore, after in vivo implantation flat constructs derived from auricular chondrocytes did take on their After expansion in monolayer, flat constructs were made by seeding the cells in a Transwell culture system stable native cartilage subtype, including elastin and collagen X production. Flat constructs derived from nasoand culturing for 14 days on chondrogenic differentiation medium. Both auricular chondrocytes and nasosepseptal chondrocytes, on the other hand, did not as collagen X was still present in the matrix. However, although tal chondrocytes had produced a cartilage-like matrix consisting of abundant collagen II and scarce collagen collagen X was present in flat constructs from both cell sources indicating hypertrophy, a stable cartilage was X expression. Similar to what was seen in the pellet cultures, cartilage constructs from auricular chondrocytes produced that did not mineralize. had produced more collagen II and were larger than conMicroarray Data structs from nasoseptal chondrocytes. Moreover, biochemical analysis demonstrated that the matrix of auricIn the two donors (age 28, 47) used for microarray study auricular chondrocytes had gone through 4.7 popular constructs contained significantly (p < 0.0005) more GAG than matrix of nasoseptal constructs (20.8 ± 5.2 ulation doublings at P2 and nasoseptal chondrocytes had gone through 5.4 population doublings. At P6 cells from µg GAG/µg DNA vs. 7.8 ± 2.4 µg GAG/µg DNA). Therefore, the difference in size of the cartilage conboth origins had gone through 15.5 and 14.2 population doublings, respectively. structs was primarily due to matrix production and not proliferation. In agreement with these findings, flat conVariation in gene expression in the microarray samples was primarily due to cell source with an average F structs from auricular chondrocytes were more solid than flat constructs from nasoseptal chondrocytes. Howratio of 5.32, and not to donor variation with an F ratio of 1.76 (Fig. 1) . Further analysis demonstrated a group ever, constructs from both cell sources were still very flexible and fragile after 14 days of in vitro differentiaof 1,090 genes whose expression was significantly different in auricular and nasoseptal chondrocytes (out of tion.
After 6 weeks of implantation in a nude mouse all 17,881 studied genes in total), of which 487 genes showed a fold difference of 2 or more. No significant after expansion. These specific molecular signatures are not only indicative of cartilage subtype characteristics difference was observed in the expression of collagen II, FGFR3, BMP2, and ALK1, which were previously (e.g., elastic), but also reflect different developmental processes. reported as markers predicting the capacity of expanded articular chondrocytes to produce cartilage (8). DISCUSSION Of these significantly differentially expressed genes, 58 genes were more than fivefold higher expressed in This study demonstrates that both auricular and nasoseptal chondrocytes are promising candidate cell sources auricular chondrocytes compared to nasoseptal chondrocytes (Table 1 ). This list is headed by proteoglycan 4 to generate cartilage for possible future reconstructions. Both cell sources were capable of producing cartilage. (88×), a matrix molecule with a lubrication function. Surprisingly, two growth factors with a known anabolic Although both produced collagen X, a marker for hypertrophic differentiation, tissue-engineered cartilage coneffect on cartilage production were observed in this list of genes expressed higher in auricular chondrocytes than structs (both pellets and flat constructs) of these cells were stable and did not mineralize. This was demonin nasoseptal chondrocytes: BMP5 (37×) and IGF1 (9×).
As expected from the production of elastin in vivo in strated in an in vitro model, as well as in vivo after subcutaneous implantation. A microarray study characthe previous experiment, eight times more elastin was expressed in auricular chondrocytes. Fibrillin 2, a glycoterized these chondrocytes more profoundly, and revealed that chondrocytes from ear and nasal septum are protein essential for the formation of elastic fibers, was also expressed significantly higher (7×) in auricular different even after expansion and these differences provide possible explanations for the observed higher machondrocytes (Table 2 ). Other components of the elastic fiber, such as fibrillin 1 and 3 or the EMILINs (elastin trix production by auricular compared to nasoseptal chondrocytes. microfibril interface located protein), were not significantly differentially expressed.
This study was the first to examine subtype and stability of tissue-engineered constructs of human auricular Forty-nine genes were more than fivefold higher expressed in nasoseptal chondrocytes (Table 2 ). In conand nasoseptal chondrocytes. Human cells were used in our study, while most other publications have studied trast, no anabolic growth factors were prominent among the genes that were higher expressed in nasoseptal chonchondrocytes from different locations in the body in rabbit (14), bovine (18) , and porcine samples (4, 30, 44 ). Androcytes than in auricular chondrocytes. In this list matrix degrading enzymes MMP13 (39x) and ADAMTS5 other strong point of this study was the elimination of donor differences, which usually contributes to a lot of (5x) were prominent.
The 487 genes that were significantly differentially noise in the data sets. In our study, auricular chondrocytes seemed to proexpressed in auricular and nasoseptal chondrocytes with a fold difference of ≥ 2 were analyzed with Functional duce more cartilage than nasoseptal chondrocytes, confirming a previous study (1, 14) . Although we cannot exAnnotation Clustering in DAVID (Table 3) . This analysis indentified "development" as the most important proclude that this was related to an increased proliferation rate of nasoseptal chondrocytes, a study performed by cess in which these genes are involved (enrichment score: 13.3). Second in line of importance were proTay et al. (38) indicated that the increased proliferation rate of nasoseptal chondrocytes did not influence matrix cesses related to "glycoproteins" (enrichment score: 4.83).
To validate the microarray results, RT-PCR was perproduction. Our microarray study did offer a possible explanation for the observed higher matrix production formed on the three genes with the highest fold difference (STEAP4, PRG4, ALX1), as well as the three by auricular chondrocytes. It did not show a different expression of predictive markers of chondrogenic capacgenes with a fold difference closest to 2 (TMED3, IL31RA, GRK5). PCR confirmed the trend and order of ity in auricular or nasoseptal chondrocytes (collagen II, BMP2, FGFR3 or ALK1) (8). However, it did demonmagnitude in fold difference as observed in the microarray data, indicating the reliability of the data sets (Tastrate that two growth factors with a known anabolic effect on cartilage matrix production, BMP5 (24) and ble 4).
In conclusion, although no difference was observed IGF1 (20) , were significantly higher expressed in auricular chondrocytes. On the other hand, two enzymes inin mRNA expression of known markers correlated with chondrogenic capacity, auricular chondrocytes do seem volved in cartilage matrix degradation, MMP13 and ADAMTS5, were expressed significantly higher in nato be characterized by a higher expression of anabolic growth factors, while matrix degrading enzymes showed soseptal chondrocytes. This is in line with recent results of Asawa et al. (1), who found a higher expression of a higher expression in nasoseptal chondrocytes. Moreover, chondrocytes from different specific donor sites MMP1, MMP2, MMP3, MMP13, and cathepsin B in nasal septum chondrocytes compared to auricular chonseem to preserve specific molecular characteristics even drocytes in 3D conditions. In this study they also demcartilage and is therefore likely contaminating cultures. Undifferentiated progenitor cells in this cambium layer onstrate that the expression of MMP13 and cathepsin B was already higher in nasal chondrocytes compared to are known for their capacity for cartilage regeneration (9, 36, 39, 42) . This may explain why culturing chondroauricular chondrocytes in the monolayer condition. Moreover, in our study the cluster "glycoprotein" was cytes with these progenitor cells from the cambium leads to a cartilage matrix that contains collagen X. Beidentified by functional annotation clustering as a main target of the genes expressed differently in auricular and cause pellets of both auricular and nasoseptal chondrocytes demonstrated collagen X in the matrix, we studied nasoseptal chondrocytes.
Cells isolated from auricular and nasoseptal cartilage their tendency to mineralize in an in vitro model. While BMSCs mineralized in this in vitro model, cartilage-like produce collagen X as well as collagen II, confirming results of Naumann et al. (29) . The subtype of the origiconstructs of both auricular and nasoseptal chondrocytes did not and were considered stable. The stability of aunal donor site does not influence terminal differentiation, as expanded auricular (elastic) and nasoseptal (hyaricular and nasoseptal chondrocytes was further confirmed by implanting tissue-engineered constructs in line) chondrocytes both produced collagen X, while this molecule is only present in native auricular cartilage.
vivo. Although auricular chondrocytes had produced elasIn addition, collagen X production was not induced by expansion and dedifferentiation as even primary auricutin after 6 weeks of in vivo implantation, preceded by 2 weeks of in vitro differentiation, it was not produced lar chondrocytes produced abundant collagen X. The observed difference between chondrocytes from articular after 10 weeks of in vitro culture alone, even when primary chondrocytes were used. Other studies have demjoints and the head and neck area could be caused by the presence of the perichondrium in both nasoseptal and onstrated as well that elastin was produced by expanded auricular chondrocytes implanted directly in vivo ( ing that developmental differences in timing and molec- tail, as these cells seem to have great potential for carti-
